Equity Overview
Price & Market Data
Price: $0.004
Daily Change: +$0.0039 / 97.50%
Daily Range: $0.004 - $0.004
Market Cap: $4,415
Daily Volume: 250
Performance Metrics
1 Week: 3,900%
1 Month: 3,900%
3 Months: 3,900%
6 Months: 399,900%
1 Year: 399,900%
YTD: 399,900%
Details
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.